AbbVie (NYSE: ABBV) will host a virtual immunology strategic update for investors on Monday, December 14, 2020 at 9:00 a.m. Central time. Richard A. Gonzalez, chairman of the board and chief executive officer, and members of the executive leadership team will present on AbbVie’s immunology business and pipeline.
NORTH CHICAGO, Ill., Dec. 1, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) will host a virtual immunology strategic update for investors on Monday, December 14, 2020 at 9:00 a.m. Central time. Richard A. Gonzalez, chairman of the board and chief executive officer, and members of the executive leadership team will present on AbbVie’s immunology business and pipeline. A live audio webcast of the presentation will be accessible through AbbVie’s Investor Relations website at investors.abbvie.com. An archived edition of the webcast will be available later that day. About AbbVie
View original content:http://www.prnewswire.com/news-releases/abbvie-to-host-virtual-immunology-strategic-update-301181943.html SOURCE AbbVie | ||
Company Codes: NYSE:ABBV |